Having spent many years as a clinician counseling individuals and families affected by ovarian and pancreatic cancer, I understand the importance of identifying individuals at high risk for these highly fatal cancers so that options for medical management and opportunities to participate in clinical research can be presented. One of my chief interests relates to identifying inherited genetic variants that may predispose to the development and/or progression of these diseases. Knowledge of such genetic variants may also help to inform the molecular mechanisms underlying these cancers. MicroRNAs are one class of molecular markers that play a key role in the development and progression of both ovarian and pancreatic cancer. As such, I am particularly interested in evaluating microRNAs as potential biomarkers and targets for early detection prevention, prognostic, and therapeutic efforts.